| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000023921 |
| Receipt No. | R000027545 |
| Scientific Title | Tricuspid annular plane systolic excursion / Left Ventricular Outflow Tract Velocity Time Integral (TAPSE / LVOT VTI) ratio to predict fluid responsiveness in mechanically ventilated patients: a pilot study |
| Date of disclosure of the study information | 2016/09/03 |
| Last modified on | 2021/03/08 (Ver. 2) |
| Basic information | ||
| Public title | Tricuspid annular plane systolic excursion / Left Ventricular Outflow Tract Velocity Time Integral (TAPSE / LVOT VTI) ratio to predict fluid responsiveness in mechanically ventilated patients: a pilot study | |
| Acronym | TAPSE / LVOT VTI ratio to predict fluid responsiveness | |
| Scientific Title | Tricuspid annular plane systolic excursion / Left Ventricular Outflow Tract Velocity Time Integral (TAPSE / LVOT VTI) ratio to predict fluid responsiveness in mechanically ventilated patients: a pilot study | |
| Scientific Title:Acronym | TAPSE / LVOT VTI ratio to predict fluid responsiveness | |
| Region |
|
|
| Condition | ||||||||||
| Condition | Hemodynamic unstability | |||||||||
| Classification by specialty |
|
|||||||||
| Classification by malignancy | Others | |||||||||
| Genomic information | NO | |||||||||
| Objectives | |
| Narrative objectives1 | The aim of this study is to evaluate the usefulness of TAPSE/LVOT VTI ratio and to find the cutoff value of TAPSE/LVOT VTI ratio to predict fluid responsiveness in critically ill patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Fluid responsiveness |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Mechanically ventilated patients with at least one of the clinical findings of tissue hypoperfusion for whom the attending physicians decided to conduct rapid fluid challenge test in the absence of contraindication for fluid infusion will be include in this study. Clinical signs of tissue hypoperfusion are defined as follows. a) Systolic blood pressure < 90 mm Hg (or a decrease < 50 mm Hg in previously hypertensive patients) or the need for vasopressive drugs (dopamine or norepinephrine); b) urine output < 0.5 mL/kg/hr for in 2 hrs; c) tachycardia (heart rate > 100/min); or d) presence of skin mottling | |||
| Key exclusion criteria | The patients whose TAPSE and LVOT VTI cannot be obtained on transthoracic echocardiogram (TTE) will be also excluded. | |||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokyo Bay Urayasu Ichikawa Medical Center | ||||||
| Division name | Emergency and critical care medicine | ||||||
| Zip code | 223-0064 | ||||||
| Address | Yokohama, Japan | ||||||
| TEL | 047-351-3101 | ||||||
| norisue.yasuhiro@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokyo Bay Urayasu Ichikawa Medical Center | ||||||
| Division name | Emergency and critical care medicine | ||||||
| Zip code | 223-0064 | ||||||
| Address | Yokohama, Japan | ||||||
| TEL | 047-351-3101 | ||||||
| Homepage URL | |||||||
| norisue.yasuhiro@gmail.com | |||||||
| Sponsor | |
| Institute | No sponsor |
| Institute | |
| Department | |
| Funding Source | |
| Organization | No funding |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo Bay Urayasu Ichikawa Medical Center |
| Address | Yokohama, Japan |
| Tel | 0473513101 |
| norisue.yasuhiro@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | No other information yet |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027545 |